<DOC>
	<DOCNO>NCT00872872</DOCNO>
	<brief_summary>Three-drug combination antiretroviral regimen use increasingly HIV-infected pregnant woman worldwide , prevention mother child transmission HIV ( PMTCT ) woman 's health . Use drug pregnant woman solely PMTCT mean drug need discontinue majority woman delivery . Certain antiretroviral regimen contain drug long half-life ( drug stay body long period time discontinuation drug regimen ) , nevirapine ( NVP ) . HIV easily develop resistance NVP NVP drug leave body ( similar monotherapy ) . Given two drug 1 week discontinue NVP ( mimic three-drug regimen wait NVP elimination ) help reduce , eliminate , development resistant virus . Unfortunately , NVP-containing regimen widely use regimen pregnant woman develop country due low cost availability fixed-dose combination . These study explore fast NVP eliminate woman delivery see give zidovudine/lamivudine ( AZT/3TC ) 1 2 week NVP discontinuation help reduce development NVP resistant virus .</brief_summary>
	<brief_title>Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy ( HAART ) Prevention Mother Child Transmission HIV ( PMTCT )</brief_title>
	<detailed_description />
	<mesh_term>Nevirapine</mesh_term>
	<criteria>1 . Willing able provide 2 separate write informed consent take part Thai Red Cross PMTCT program study 2 . Female aged 1845 year 3 . Documented HIV1 infection 4 . Pregnant maximum 36 week first dose study medication 5 . Baseline CD4 cell count &gt; 250 cells/mm3 6 . Intend discontinue ART delivery 1 . History significant reaction allergy drug may use study 2 . Antiretroviral ( ARV ) experience include previous ARV use prevention mothertochild transmission HIV 3 . Documented NVP 3TCresistant HIV1 strain 4 . Concomitant use medication interfere NVP plasma level 5 . Serum aspartate transaminase ( AST ) alanine transaminase ( ALT ) &gt; 1.25 time upper limit normal 6 . Inability understand nature extent trial procedure require 7 . Pregnant woman , opinion investigator , participate study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>NVP</keyword>
	<keyword>PMTCT</keyword>
	<keyword>pregnancy</keyword>
	<keyword>resistance</keyword>
</DOC>